AU6229696A - Novel heteroaromatic piperazines for use as drugs - Google Patents
Novel heteroaromatic piperazines for use as drugsInfo
- Publication number
- AU6229696A AU6229696A AU62296/96A AU6229696A AU6229696A AU 6229696 A AU6229696 A AU 6229696A AU 62296/96 A AU62296/96 A AU 62296/96A AU 6229696 A AU6229696 A AU 6229696A AU 6229696 A AU6229696 A AU 6229696A
- Authority
- AU
- Australia
- Prior art keywords
- piperazines
- drugs
- novel heteroaromatic
- heteroaromatic
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9506825A FR2735127B1 (en) | 1995-06-09 | 1995-06-09 | NEW HETEROAROMATIC PIPERAZINES USEFUL AS MEDICAMENTS. |
| FR9506825 | 1995-06-09 | ||
| PCT/FR1996/000853 WO1996041802A1 (en) | 1995-06-09 | 1996-06-06 | Novel heteroaromatic piperazines for use as drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6229696A true AU6229696A (en) | 1997-01-09 |
Family
ID=9479790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62296/96A Abandoned AU6229696A (en) | 1995-06-09 | 1996-06-06 | Novel heteroaromatic piperazines for use as drugs |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU6229696A (en) |
| FR (1) | FR2735127B1 (en) |
| WO (1) | WO1996041802A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2761068B1 (en) * | 1997-03-20 | 1999-04-23 | Synthelabo | PIPERAZIN-4-YLTHIENO [3,2-C] PYRIDIN-4-YL-2- CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| WO2003101964A1 (en) | 2002-05-31 | 2003-12-11 | Takeda Pharmaceutical Company Limited | Piperidine derivative, process for producing the same, and use |
| TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
| CA2668959A1 (en) | 2006-11-09 | 2008-05-15 | F. Hoffmann-La Roche Ag | Indole and benzofuran 2-carboxamide derivatives |
| NZ577114A (en) | 2006-12-19 | 2011-12-22 | Hoffmann La Roche | Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| WO2010105243A1 (en) | 2009-03-13 | 2010-09-16 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| JP5756457B2 (en) | 2009-04-06 | 2015-07-29 | アジオス ファーマシューティカルズ， インコーポレイテッド | Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use |
| US8785450B2 (en) | 2009-06-29 | 2014-07-22 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| WO2011002816A1 (en) | 2009-06-29 | 2011-01-06 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| EP3561077B1 (en) | 2009-10-21 | 2022-12-21 | Les Laboratoires Servier | Methods for cell-proliferation-related disorders |
| CA2793836C (en) | 2009-10-21 | 2020-03-24 | Agios Pharmaceuticals, Inc. | Methods and compositions for cell-proliferation-related disorders |
| JP5967827B2 (en) * | 2009-12-09 | 2016-08-10 | アジオス ファーマシューティカルズ， インコーポレイテッド | Therapeutically active compounds for the treatment of cancer characterized by having an IDH variant |
| EP2651898B1 (en) | 2010-12-17 | 2015-12-09 | Agios Pharmaceuticals, Inc. | Novel n-(4-(azetidine-1-carbonyl)phenyl)-(hetero-)arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators |
| EP2655350B1 (en) | 2010-12-21 | 2016-03-09 | Agios Pharmaceuticals, Inc. | Bicyclic pkm2 activators |
| TWI549947B (en) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | Therapeutic compounds and compositions |
| PL3406251T3 (en) | 2011-05-03 | 2024-04-29 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
| CN102827073A (en) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | Therapeutically active compositions and application methods thereof |
| CN102827170A (en) | 2011-06-17 | 2012-12-19 | 安吉奥斯医药品有限公司 | Active treatment compositions and use method thereof |
| SI2800743T1 (en) | 2012-01-06 | 2018-08-31 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| US9474779B2 (en) | 2012-01-19 | 2016-10-25 | Agios Pharmaceuticals, Inc. | Therapeutically active compositions and their methods of use |
| WO2014062511A1 (en) | 2012-10-15 | 2014-04-24 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| WO2015003355A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| EP3019480B1 (en) | 2013-07-11 | 2020-05-06 | Agios Pharmaceuticals, Inc. | 2,4- or 4,6-diaminopyrimidine compounds as idh2 mutants inhibitors for the treatment of cancer |
| US9579324B2 (en) | 2013-07-11 | 2017-02-28 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| WO2015003360A2 (en) | 2013-07-11 | 2015-01-15 | Agios Pharmaceuticals, Inc. | Therapeutically active compounds and their methods of use |
| US20150031627A1 (en) | 2013-07-25 | 2015-01-29 | Agios Pharmaceuticals, Inc | Therapeutically active compounds and their methods of use |
| KR102400737B1 (en) | 2014-03-14 | 2022-05-20 | 아지오스 파마슈티컬스 아이엔씨. | Pharmaceutical compositions of therapeutically active compounds |
| WO2016201227A1 (en) | 2015-06-11 | 2016-12-15 | Agios Pharmaceuticals, Inc. | Methods of using pyruvate kinase activators |
| MD3362066T2 (en) | 2015-10-15 | 2022-08-31 | Les Laboratoires Servier Sas | Combination therapy for treating malignancies |
| EP4403173A3 (en) | 2015-10-15 | 2024-10-09 | Les Laboratoires Servier | Combination therapy for treating malignancies |
| US10980788B2 (en) | 2018-06-08 | 2021-04-20 | Agios Pharmaceuticals, Inc. | Therapy for treating malignancies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436246A (en) * | 1992-09-17 | 1995-07-25 | Merrell Dow Pharmaceuticals Inc. | Serotonin receptor agents |
| DK148392D0 (en) * | 1992-12-09 | 1992-12-09 | Lundbeck & Co As H | Heterocyclic Compounds |
| GB9300195D0 (en) * | 1993-01-06 | 1993-03-03 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1995
- 1995-06-09 FR FR9506825A patent/FR2735127B1/en not_active Expired - Fee Related
-
1996
- 1996-06-06 AU AU62296/96A patent/AU6229696A/en not_active Abandoned
- 1996-06-06 WO PCT/FR1996/000853 patent/WO1996041802A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| FR2735127B1 (en) | 1997-08-22 |
| FR2735127A1 (en) | 1996-12-13 |
| WO1996041802A1 (en) | 1996-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6229696A (en) | Novel heteroaromatic piperazines for use as drugs | |
| AU1667795A (en) | Pharmaceutical piperazine compounds | |
| AU3173095A (en) | Novel pharmaceutical product | |
| AU6517196A (en) | Piperazine derivatives as therapeutic agents | |
| AU1566795A (en) | Pharmaceutical ointment base | |
| AU1608397A (en) | Heterocyclic compounds useful as pharmaceutical agents | |
| AU2533495A (en) | Pharmaceutical diketopiperazine compounds | |
| AU6995396A (en) | Pharmaceutical formulation | |
| AU6740298A (en) | Pharmaceutical composition | |
| AU7590096A (en) | Drug composition | |
| AU6973396A (en) | Pharmaceutical formulation | |
| AU1667595A (en) | Pharmaceutical piperazine compounds | |
| AU1588495A (en) | Pharmaceutical piperazin compounds | |
| AU6904896A (en) | Pharmaceutical compounds | |
| AU1599295A (en) | Pentoxifylline dosage form | |
| AU8591898A (en) | Pharmaceutical compounds | |
| AU6016896A (en) | Heterocyclic compounds, their production and use | |
| AU5155096A (en) | Pharmaceutical composition | |
| AU4330097A (en) | Pharmaceutical compounds | |
| AU3542993A (en) | Pharmaceutical compounds | |
| AU5015896A (en) | Drug containing methotrexate derivative | |
| AU2531295A (en) | Pharmaceutical composition | |
| AU7582696A (en) | Pharmaceutical formulation | |
| AU4169897A (en) | Pharmaceutical compounds | |
| AU1475595A (en) | Pharmaceutical preparation |